Clinical Evidence on EndoClot PHS: Explore the Latest Research Findings
Discover the latest and most relevant clinical evidence on EndoClot Polysaccharide Hemostatic System (PHS) through our curated list of research findings. EndoClot PHS is an advanced powder hemostat that is applied during a procedure using consistent air pressure, intended to provide more control of delivery. This page serves as a resource for researchers, clinicians, and healthcare professionals interested in staying informed about the efficacy and impact of EndoClot PHS in managing gastrointestinal bleeding. Each entry includes a link to the abstract for further reading.
Hemostatic powder application for control of acute upper gastrointestinal bleeding in patients with gastric malignancy
| Author |
Yeong Jin Kim et al. |
| Publication Year |
2018 |
| Journal |
Endoscopy international open |
Comparison of Hemospray and EndoClot for the treatment of gastrointestinal bleeding
| Author |
Francesco Vitali et al. |
| Publication Year |
2019 |
| Journal |
World journal of gastroenterology |
Efficacy of hemostatic powders in upper gastrointestinal bleeding: A systematic review and meta-analysis
| Author |
Antonio Facciorusso et al. |
| Publication Year |
2019 |
| Journal |
Digestive and liver disease |
Comparison of a polysaccharide hemostatic powder and conventional therapy for peptic ulcer bleeding
| Author |
Da Hyun Jung et al. |
| Publication Year |
2023 |
| Journal |
Clinical gastroenterology and hepatology |
The information on this page was last updated on March 6, 2025.
